Log In
BCIQ
Print this Print this
 

SR-IFN alpha

  Manage Alerts
Collapse Summary General Information
Company LG Life Sciences Ltd.
DescriptionSustained release interferon (INF) alpha
Molecular Target Type I interferon (IFN) receptor
Mechanism of ActionType I interferon (IFN) receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat hepatitis C virus (HCV) infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today